U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C27H31N9O15P2.2Na
Molecular Weight 829.5134
Optical Activity UNSPECIFIED
Defined Stereocenters 7 / 7
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FLAVIN ADENINE DINUCLEOTIDE DISODIUM

SMILES

[Na+].[Na+].CC1=C(C)C=C2N(C[C@H](O)[C@H](O)[C@H](O)COP([O-])(=O)OP([O-])(=O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)N4C=NC5=C(N)N=CN=C45)C6=NC(=O)NC(=O)C6=NC2=C1

InChI

InChIKey=XLRHXNIVIZZOON-WFUPGROFSA-L
InChI=1S/C27H33N9O15P2.2Na/c1-10-3-12-13(4-11(10)2)35(24-18(32-12)25(42)34-27(43)33-24)5-14(37)19(39)15(38)6-48-52(44,45)51-53(46,47)49-7-16-20(40)21(41)26(50-16)36-9-31-17-22(28)29-8-30-23(17)36;;/h3-4,8-9,14-16,19-21,26,37-41H,5-7H2,1-2H3,(H,44,45)(H,46,47)(H2,28,29,30)(H,34,42,43);;/q;2*+1/p-2/t14-,15+,16+,19-,20+,21+,26+;;/m0../s1

HIDE SMILES / InChI

Description
Curator's Comment: description was created based on several sources, including: http://www.wikidoc.org/index.php/FAD http://www.drugbank.ca/drugs/DB03147

Flavin adenine dinucleotide is a coenzyme form of vitamin B2. Many oxidoreductases, called flavoenzymes or flavoproteins, require FAD as a prosthetic group, which functions in electron transfers. It is usually used for the prevention and treatment of various diseases that are caused by Vitamin B2 deficiency or metabolic disorder including stomatitis, eczema, etc. No adverse reactions were reported.

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Palliative
Flavitan

Approved Use

It is usually used for the prevention and treatment of various diseases that are caused by Vitamin B2 deficiency

Launch Date

1966
Palliative
Flavitan

Approved Use

It is an effective in conjunctivitis treatment.

Launch Date

1966
Palliative
Flavitan

Approved Use

It is usually used for the prevention and treatment of metabolic disorder including stomatitis.

Launch Date

1966
PubMed

PubMed

TitleDatePubMed
Flavin adenine dinucleotide concentration in erythrocytes with normal and deficient glucose-6-phosphate dehydrogenase.
1970 Sep 1
Structure of fumarate reductase from Wolinella succinogenes at 2.2 A resolution.
1999 Nov 25
Enzymatic and non-enzymatic reduction of brucine N-oxide by aldehyde oxidase and catalase.
2001 Nov
Patents

Patents

Sample Use Guides

Oral: Take 5 to 45 mg of flavin adenine dinucleotide per day in 1 to 3 divided doses. Injection: 40 mg one or two times per day
Route of Administration: Other
In Vitro Use Guide
The addition of 1uM of FAD was found to exert a consistent activation effect on Glutathione reductase activity.
Name Type Language
FLAVIN ADENINE DINUCLEOTIDE DISODIUM
Common Name English
FLAVIN ADENINE DINUCLEOTIDE SODIUM [JAN]
Common Name English
DISODIUM FLAVINE ADENINE DINUCLEOTIDE [INCI]
Common Name English
FAD SODIUM SALT
Common Name English
FLAVIN ADENINE DINUCLEOTIDE SODIUM SALT
Common Name English
RIBOFLAVIN 5'-(TRIHYDROGEN DIPHOSPHATE), P'->5'-ESTER WITH ADENOSINE, DISODIUM SALT
Systematic Name English
DISODIUM FLAVINE ADENINE DINUCLEOTIDE
INCI  
INCI  
Official Name English
Flavine adenine dinucleotide disodium [WHO-DD]
Common Name English
FLAVINE ADENINE DINUCLEOTIDE DISODIUM
WHO-DD  
Common Name English
Code System Code Type Description
EPA CompTox
DTXSID0046723
Created by admin on Sat Dec 16 09:30:19 GMT 2023 , Edited by admin on Sat Dec 16 09:30:19 GMT 2023
PRIMARY
SMS_ID
100000078480
Created by admin on Sat Dec 16 09:30:19 GMT 2023 , Edited by admin on Sat Dec 16 09:30:19 GMT 2023
PRIMARY
FDA UNII
67U7UHJ04C
Created by admin on Sat Dec 16 09:30:19 GMT 2023 , Edited by admin on Sat Dec 16 09:30:19 GMT 2023
PRIMARY
DRUG BANK
DBSALT000903
Created by admin on Sat Dec 16 09:30:19 GMT 2023 , Edited by admin on Sat Dec 16 09:30:19 GMT 2023
PRIMARY
CAS
84366-81-4
Created by admin on Sat Dec 16 09:30:19 GMT 2023 , Edited by admin on Sat Dec 16 09:30:19 GMT 2023
PRIMARY
PUBCHEM
2734019
Created by admin on Sat Dec 16 09:30:19 GMT 2023 , Edited by admin on Sat Dec 16 09:30:19 GMT 2023
PRIMARY
EVMPD
SUB13893MIG
Created by admin on Sat Dec 16 09:30:19 GMT 2023 , Edited by admin on Sat Dec 16 09:30:19 GMT 2023
PRIMARY